Nabriva Therapeutics plc Other Accrued Liabilities, Current
Nabriva Therapeutics plc had Other Accrued Liabilities, Current of $944.00 thousand as of 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2023-10-19
- 2023-06-30: Other Accrued Liabilities, Current $944.00K.
- 2023-03-31: Other Accrued Liabilities, Current $939.00K.
- 2022-12-31: Other Accrued Liabilities, Current $1.29M.
- 2022-09-30: Other Accrued Liabilities, Current $1.22M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2023-06-30 | $944.00K 10-Q · filed 2023-10-19 | |
| 2023-03-31 | $939.00K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $1.29M 10-Q · filed 2023-10-19 | |
| 2022-09-30 | $1.22M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $973.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.30M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.50M 10-K · filed 2023-04-17 | |
| 2021-09-30 | $1.08M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.27M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.24M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.83M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.67M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.16M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.28M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.70M 10-K · filed 2021-03-11 | $3.87M 10-K · filed 2020-03-12 |
| 2019-09-30 | $3.89M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.37M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.63M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.65M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $1.79M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.73M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.86M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $1.16M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $2.79M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $985.00K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $882.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $1.78M 10-K · filed 2018-03-16 | $1.96M 10-K · filed 2017-03-24 |
| 2015-12-31 | $553.00K 10-K · filed 2017-03-24 |